期刊文献+

c—kitmRNA的表达与直肠癌术后患者预后的关系 被引量:2

Relationship between c-kit mRNA expression and prognosis in patients with rectal carcinoma
原文传递
导出
摘要 目的探讨c-kit mRNA的表达与直肠癌患者术后预后的关系。方法采用分支DNA液相芯片法检测66例直肠癌患者肿瘤组织中c-kit mRNA的表达情况,根据表达结果将患者分为c-kit mRNA低表达组和高表达组,分析c-kit mRNA的表达情况与患者临床病理特征的关系以及影响患者预后的因素。结果66例直肠癌患者中,c-kit mRNA高表达18例(27.3%),c-kit mRNA在直肠癌组织中的表达与患者的性别、年龄、术前癌胚抗原(CEA)水平、术前血红蛋白水平、肿瘤距肛缘距离、分化程度、淋巴结转移、脉管癌栓、T分期以及TNM分期均无关(均P〉0.05)。至随访结束,66例患者中,死亡34例,生存32例,复发转移36例。c-kit mRNA高表达组患者的1、3、5年生存率分别为100%、77.8%和77.8%,c-kit mRNA低表达组患者的1、3、5年生存率分别为93.8%、56.3%和45.8%,组间差异有统计学意义(P=0.025)。淋巴结转移、T分期、TNM分期也与患者的总生存有关(均P〈0.05)。c-kit mRNA高表达组患者的1、3、5年无病生存率分别为100%、77.8%和77.8%,c-kit mRNA低表达组患者的1、3、5年无病生存率分别为77.1%、43.8%和41.7%,组间差异有统计学意义(P=0.044)。c-kit mRNA的表达(P=0.038)和TNM分期(P=0.039)是影响直肠癌患者总生存的独立因素。结论c-kit低表达与直肠癌的不良预后有关,其影响直肠癌患者预后的机制值得进一步探究。 Objective To investigate the correlation between c-kit mRNA expression and prognosis in patients with rectal carcinoma. Methods The expression of c-kit mRNA in rectal carcinoma tissues(n = 66) was detected by multiplex branched-DNA liquid chip method. According to the expression level, the patients were classified into the c-kit mRNA high expression group and the low group. We analyzed the relationship between the c-kit mRNA expression and the clinicopathological characteristics of patients, as well as the factors affecting patients'prognosis. Results Of the 66 rectal carcinoma patients, 18 (27.3%) cases were c-kit mRNA high expression. No significant correlation was found between the c-kit mRNA expression and gender, age, preoperative carcinoembryonic antigen, preoperative hemoglobin, distance to verge, lymph node metastasis, tumor thrombus, T stage, TNM stage and tumor differentiation (P〉0.05). In follow-up, 34 patients died, 32 patients and 36 patients were recurrence or metastasis. The 1-, 3-, 5-year overall survival(OS) of c-kit mRNA high expression group were 100.0%, 77.8%, 77.8%, respectively, while those of the low one were 93.8%, 56.3%, 45.8%, respectively. The difference was statistically significant( P= 0.025). Lymph node metastasis, T stage and TNM stage were also significant associated with OS(P〈0.05). The 1-, 3-, 5-year disease free rate (DFS)of the c-kit mRNA high expression group were 100.0%,77.8% and 77.8%, respectively, while those of the low one were 77.1%,43.8% and 41.7%, respectively, and the difference between the two groups was significant ( P = 0.044). As a reslut, c-kit mRNA expression (P= 0.038) and TNM stage (P= 0.039) were the independent prognostic factors affecting the OS in rectal cancer patients. Conclusions Low expression of c-kit was associated with poor prognosis of rectal carcinoma. And the mechanism underlying this phenomenon deserves further exploration.
作者 林延宗 黄云霞 应敏刚 孔祥泉 林凤村 Lin Yanzong;Huang Yunxia;Ying Mingang;Kong Xiangquan;Lin Fengcun(Department of Gastrointestinal Surgical Oncology,Fujian Medical University Cancer Hospital,Fuzhou 350014,China(Lin YZ,Ying MG;Department of Abdominal Radiation Oncology,Fufian Medical University Cancer Hospital,Fuzhou 350014,China(Huang YX,Kong XQ;Department of Radiation Oncology,Zhangzhou Hospital Affiliated to Fujian Medical University,Zhangzhou 363000,China(Lin FC)
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2018年第9期667-671,共5页 Chinese Journal of Oncology
关键词 直肠肿瘤 c—kit MRNA 基因表达 预后 Rectal neoplasms C-kit mRNA Gene expression Prognosis
  • 相关文献

参考文献6

二级参考文献82

  • 1孙蕾娜,哈斯,战忠利.小细胞肺癌c-Kit基因蛋白的表达及其与预后的关系[J].中国肿瘤临床,2005,32(2):87-88. 被引量:2
  • 2梅峰,于彬,马华,张红军,周德山.豚鼠空肠吻合术后ICCs的再生及细胞网络再形成研究[J].第三军医大学学报,2005,27(5):376-380. 被引量:4
  • 3袁芃,缪小平,张雪梅,王中华,谭文,张湘茹,孙燕,徐兵河,林东昕.核苷酸切除修复系统基因遗传多态与晚期非小细胞肺癌患者铂类药物敏感性关系[J].癌症,2005,24(12):1510-1513. 被引量:46
  • 4CONRY R M,CURIEL D T,STRONG T V,et al.Safety and immunogenicity of a DNA vaccine encoding carcinoembryonic antigen and hepatitis B surface antigen in colorectal carcinoma patients[J].Clin Cancer Res,2002,8(9):2782-2787.
  • 5HANNA M G,Jr.,HOOVER H C,Jr.,VERMORKEN J B,et al.Adjuvant active specific immunotherapy of stage II and stage III colon cancer with an autologous tumor cell vaccine:first randomized phase III trials show promise[J].Vaccine,2001,19(17-19):2576-2582.
  • 6BELLONE G,CARBONE A,SIBONA N,et al.Aberrant activation of C-KIT protects colon carcinoma cells against apoptosis and enhances their invasive potential[J].Cancer Res,2001,61(5):2200-2206.
  • 7BELLONE G,SILVESTRI S,ARTUSIO E,et al.Growth stimulation of colorectal carcinoma cells via the C-KIT receptor is inhibited by TGF-beta 1[J].J Cell Physiol,1997,172(1):1-11.
  • 8YORKE R,CHIRALA M,YOUNES M.C-KIT proto-oncogene product is rarely detected in colorectal adenocarcinoma[J].J Clin Oncol,2003,21(20):3885-3886.
  • 9SAMMARCO I,CAPURSO G,COPPOLA L,et al.Expression of the proto-oncogene C-KIT in normal and tumor tissues from colorectal carcinoma patients[J].Int J Colorectal Dis,2004,19(6):545-553.
  • 10REMMELE W,STEGNER H E.Recommendation for uniform definition of an immunoreactive score(IRS) for immunohistochemical estrogen receptor detection(ER-ICA) in breast cancer tissue[J].Pathologe,1987,8(3):138-140.

共引文献23

同被引文献15

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部